Skip to content

Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations

Reducing Scan Times and Improving Care Through Quantitative Imaging: Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03494855
Acronym
SyMRI
Enrollment
5
Registered
2018-04-11
Start date
2016-06-01
Completion date
2019-01-01
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Development Abnormality, Brain Injuries, Brain Pathology

Brief summary

Synthetic MR Technologies has created a quantified imaging solution - SyMRI - to enable radiologists to acquire quantified images and always obtain the best contrast images. This study represents an attempt to assess the clinical utility of this software.

Detailed description

Typical magnetic resonance imaging (MRI) involves taking many images called 'contrasts' to look at the body in different ways. Standard scan settings are usually good enough for a radiologist to review. The best settings often change with the age of the patient and their health, and are time consuming to determine. Quantified imaging is an alternative to contrast-based imaging which explicitly measures tissue properties and can be used to create almost any contrast. This method of imaging has been held back by a lack of the right software. Synthetic MR Technologies has created a quantified imaging solution - SyMRI - to enable radiologists to acquire quantified images and always obtain the best contrast images. The objective of this study is to evaluate SyMRI in a pediatric population to determine if Sickkids would be interested in purchasing this product / support Health Canada approval. Specifically, the investigators are interested in determining if SyMRI is clinically useful: * Is synthetic imaging quality comparable / better than conventional imaging? * Qualitative - Are radiologists more confident using synthetic MR vs conventional * Quantitative - Signal-to-noise (SNR) and Contrast-to-noise (CNR) * To what extent can total exam times be reduced? * Is the software user friendly and would investigators use it?

Interventions

DEVICESyMRI Software

The MDME sequence aims to provide whole absolute quantification of T1, T2, PD and B1 inhomogeneity in 5 minutes at typical clinical resolution (0.8 x 0.8 x 5mm). SyMRI software then allows a user to synthesize any almost image contrast (T1, T2, PD, FLAIR, IR, DIR, etc) by adjusting imaging parameters after the fact.

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any stable patient undergoing clinical MRI of the brain is eligible for this study. * Research patients undergoing research MRI of the brain for another study will be eligible.

Exclusion criteria

* Only those patients where an additional 10 minutes of MR imaging would not be advisable (ie. unstable, implants) or possible (due to scheduling constraints) will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Quality relative to conventional imagingThrough study completion, an average of 1 yearRadiologist compares qualitative diagnostic quality of SyMRI imaging against Conventional Imaging. Measure - Poorer, Equal, Better

Secondary

MeasureTime frameDescription
Scan time for SyMRI vs Conventional MRThrough study completion, an average of 1 yearCompare acquisition time for SyMRI scans vs Conventional MR Measure - Minutes:Seconds

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026